Now in its third edition, Oncology Board Review: Blueprint Study Guide and Q&A is designed to help you prepare for the American Board of Internal Medicine (ABIM) Medical Oncology Certification Exam. This comprehensive print + digital resource has been revised to include new treatment regimens, clinical guidelines, and other advancements impacting the field as well as updated board-style Q&A. Dedicated sections cover hematological malignancies and solid tumors with a templated chapter approach highlighting epidemiology, etiology and risk factors, diagnostic criteria, staging, signs and symptoms of the disease, prognostic factors, indications for treatment, and special considerations. Later sections address other topics found on the exam, including cancer genetics and tumor biology, supportive and palliative care, bone marrow transplantation, and biostatistics. With more than 240 practice questions, detailed rationales, and a convenient print + digital package, Oncology Board Review gives you the tools to study your way and the confidence to pass the first time!
Key Features:
Aligns with the latest ABIM Medical Oncology Certification Exam blueprint
Provides a comprehensive yet concise review of all hematologic malignancies and solid tumors
Covers anticancer therapies, clinical research methodology, survivorship and palliative care, and more areas found on the exam
Revised to include new treatment recommendations and FDA approvals
Includes end-of-chapter assessment questions with detailed rationales - a total of more than 240 questions throughout
Content available digitally via ExamPrepConnect for study on the go
ExamPrepConnect Features:
All the high-quality content from the book
Personalized study plan based on initial certification or MOC exam date
Ability to study by topic area to identify strengths and weaknesses
Timed practice test that simulates the test-taking environment
Discussion board to connect with Medical Oncology exam-prep community
Author(s): Francis P. Worden, Rami N. Khoriaty, Erin F. Cobain
Edition: 3
Publisher: Demos Medical, Springer Publishing
Year: 2021
Language: English
Tags: Oncology Board Review; Cancer; Hematology
Cover
Title
Copyright
Contents
Contributors
Preface
Acknowledgments
Part I: Hematologic Malignancies
Chapter 1: Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Hairy Cell Leukemia
Chapter 2: Chronic Lymphocytic Leukemia
Epidemiology
Signs and Symptoms
Diagnostic Criteria
Staging
Prognostic Factors
Indications for Treatment
Treatment
Special Considerations
Hairy Cell Leukemia
Questions
Answers
Chapter 3: Chronic Myelogenous Leukemia and Myeloproliferative Neoplasms
Chronic Myelogenous Leukemia
Polycythemia Vera
Essential Thrombocythemia
Primary Myelofibrosis
Chapter 4: Myelodysplastic Syndrome
Epidemiology
Etiology and Risk Factors
Classification
Signs and Symptoms
Diagnostic Criteria
Prognostic Factors
Indications for Treatment
Treatment
Special Considerations
Questions
Answers
Chapter 5: Hodgkin Lymphoma
Epidemiology
Etiology and Risk Factors
Staging
Signs and Symptoms
Diagnostic Criteria
Indications for Treatment
Prognostic Factors
Treatment
Response-adapted Therapy
Relapsed/refractory Disease
Novel Therapies
Special Considerations
Questions
Answers
Chapter 6: Non-Hodgkin Lymphoma
Follicular Lymphoma
Marginal Zone Lymphoma
Lymphoplasmacytic Lymphoma/waldenström Macroglobulinemia
Chapter 7: High-Grade Non-Hodgkin Lymphoma
Epidemiology
Diagnostic Workup
Staging and Special Considerations
Treatment
Diffuse Large B Cell Lymphoma
Burkitt Lymphoma
High Grade B-Cell Lymphoma
Mantle Cell Lymphoma
Primary Mediastinal B-cell Lymphoma
Aids-related B-cell Lymphomas
Posttransplant Lymphoproliferative Disorder (PTLD)
Questions
Answers
Chapter 8: T-Cell Lymphoma
Risk Factors
Perpherial T-Cell Lymphoma
Ptcl Pathology
Ptcl Prognostic Factors
Ptcl Treatment
Rare T-Cell Leukemias/Lymphomas
Questions
Answers
Chapter 9: Multiple Myeloma
Epidemiology
Etiology and Risk Factors
Screening and Diagnostic Criteria
Pathology
Signs and Symptoms
Risk Stratification
Staging
Treatment
Questions
Answers
Part II: Aerodigestive Malignancies
Chapter 10: Non–Small Cell Lung Cancer
Etiology and Risk Factors
Screening
Prevention
Pathology
Signs and Symptoms
Diagnostic Workup
Staging
Treatment
Questions
Answers
Chapter 11: Small Cell Lung Cancer
Background and Etiology
Lung Cancer Screening
Diagnosis
Staging
Treatment
Limited Stage
Extensive Stage
Surveillance
Other Clinical Pearls
Questions
Answers
Chapter 12: Mesothelioma
Epidemiology
Etiology and Risk Factors
Staging and Histological Classification
Signs, Symptoms, and Imaging Findings
Diagnosis
Prognostic Factors
Treatment
Special Considerations
Questions
Answers
Chapter 13: Thymoma
Overview
Etiology, Risk Factors, and Clinical Features
Diagnosis
Staging Classification
Outcomes
Treatment
Questions
Answers
Chapter 14: Head and Neck Cancers
Etiology and Risk Factors
Staging
Diagnostic Workup
Treatment
Location-Specific Considerations
Questions
Answers
Part III: Endocrine Malignancies
Chapter 15: Thyroid Cancers
I. Thyroid Cancers
II. Differentiated Thyroid Cancer
III. Medullary Thyroid Cancer
IV. Anaplastic Thyroid Cancer
Chapter 16: Adrenal Cortical Carcinoma
Epidemiology, Pathogenesis, and Risk Factors
Staging
Signs and Symptoms
Diagnosis
Treatment of Localized Disease
Surveillance
Treatment of Advanced Disease
Questions
Answers
Chapter 17: Pheochromocytoma
Epidemiology
Etiology and Risk Factors
Signs and Symptoms
Diagnosis
Treatment: Localized Disease
Treatment: Metastatic Disease
Prognosis and Surveillance
Questions
Answers
Part IV: Breast Cancer
Chapter 18: Breast Cancer
Etiology and Risk Factors
Staging
Questions
Answers
Part V: Genitourinary Malignancies
Chapter 19: Bladder Cancer
Pathology/Cancer Genetics
Staging
Nonmuscle Invasive Bladder Cancer
Muscle-Invasive Bladder Cancer
Locally Advanced (Node-Positive)/Metastatic Bladder Cancer
Questions
Answers
Chapter 20: Prostate Cancer
Screening
Pathology
Signs and Symptoms
Diagnosis
Genetic Testing
Staging
Indications for Treatment
Prognostic Factors
Treatment
Questions
Answers
Chapter 21: Testicular Cancer
Pathology
Diagnostic Workup
Staging
Prognostic Factors
Treatment
Special Considerations
Questions
Answers
Chapter 22: Renal Cell Carcinoma
Genetics
Staging
Signs and Symptoms
Diagnostic Workup
Prognostic Factors
Treatment
Questions
Answers
Part VI: Gastrointestinal Malignancies
Chapter 23: Esophageal Cancer
Etiology and Risk Factors
Staging
Signs and Symptoms
Workup and Diagnosis
Treatment—First Line
Treatment—Recurrent Disease
Treatment—Metastatic Disease
Special Considerations
Questions
Answers
Chapter 24: Gastric Cancer
Epidemiology
Etiology and Risk Factors
Signs and Symptoms
Staging
Diagnosis
Treatment
Questions
Answers
Chapter 25: Colon Cancer
Epidemiology
Etiology and Risk Factors
Screening
Prevention
Pathology
Signs and Symptoms
Diagnostic Workup
Prognostic and Risk Factors
Staging General Treatment Principles Colon Cancer
Treatment by Stage
Questions
Answers
Chapter 26: Anal Cancer
Epidemiology
Etiology and Risk Factors
Screening and Prevention
Pathology
Signs and Symptoms
Diagnostic Workup
Staging
General Principles of Treatment
Treatment by Stage
Questions
Answers
Chapter 27: Pancreatic and Biliary Cancers
Epidemiology
Risk Factors
Staging
Diagnostic Criteria
Prognostic Factors
Treatment
Special Considerations
Questions
Answers
Chapter 28: Hepatocellular Carcinoma
Epidemiology
Staging
Signs and Symptoms
Diagnostic Criteria
Indications for Treatment
Prognostic Factors
Treatment
Questions
Answers
Chapter 29: Neuroendocrine Tumors
Epidemiology
Pathology
Signs and Symptoms
Diagnostic Workup
Treatment
Questions
Answers
Part VII: Sarcoma
Chapter 30: Sarcoma
Closely Related to Sarcoma
Genetics and Risk Factors
Evaluation of Suspected Sarcoma
Sts Staging
Gist Staging
Osteosarcoma Staging
Treatment for Non-gist Soft Tissue Sarcoma
Treatment for Bone Sarcomas
Treatment for Gists
Kaposi Sarcoma
Questions
Answers
Part VIII: Melanoma
Chapter 31: Melanoma
Pathology
Risk Factors
Staging
Diagnosis
Prognostic Factors
Treatment of Primary/Localized Melanoma
Treatment of Metastatic Disease
Questions
Answers
Part IX: Central Nervous System Malignancies
Chapter 32: Central Nervous System Tumors
General
Part X: Gynecologic Malignancies
Chapter 33: Cervical, Vulvar, and Vaginal Cancers
Etiology, Risk Factors, and Histologic Subtypes
Staging
Treatment
Special Considerations
Questions
Answers
Chapter 34: Ovarian Cancer
Pathology
Etiology and Risk Factors
Staging
Management
Questions
Answers
Chapter 35: Endometrial Cancer
Epidemiology
Etiology and Risk Factors
Screening and Prevention
Signs and Symptoms
Staging
Pathology
Diagnostic Criteria
Prognostic Factors
Treatment
Special Considerations
Questions
Answers
Part XI: Cancer of Unknown Primary
Chapter 36: Cancer of Unknown Primary
Epidemiology
Diagnosis
Prognosis
Treatment
Questions
Answers
References
Part XII: Genetics and Tumor Biology
Chapter 37: Cancer Genetics
Introduction
Part XIII: Supportive and Palliative Care
Chapter 38: Supportive Care
Chemotherapy-induced Nausea and Vomiting
Pain Management
Constipation
Cancer Cachexia
Dyspnea
Psychiatric Syndromes
Questions
Answers
Part XIV: Bone Marrow Transplantation
Chapter 39: Stem Cell Transplantation and Cellular Therapy
Epidemiology
Classification
Eligibility
Indications
Toxicity of Conditioning Regimens
Complications of Transplant
Other Cellular Therapy (car-t)
Questions
Answers
Part XV: Biostatistics
Chapter 40: Biostatistics
Example 40.1
Example 40.2
Example 40.3
Diagnostic Tests
Clinical Study Design Biases
Clinical Study Basics
Questions
Answers
Index
